Medical Dosimetry is a distinguished journal published by Elsevier Science Inc, dedicated to the advancing field of medical dosimetry and its applications within oncology, radiology, and nuclear medicine. With its ISSN 0958-3947 and E-ISSN 1873-4022, this journal serves as a crucial resource for researchers and professionals aiming to enhance their understanding of radiation treatment planning and dosage calculations. Encompassing a comprehensive range of topics from clinical dosimetry to technology assessment, Medical Dosimetry has been disseminating significant findings since its establishment in 1988, contributing to the continuous development of best practices in patient care and safety. The journal currently holds a Q3 ranking in various categories, reflecting its pivotal role in the research community, while not currently offering open access, it remains an essential reference for scholars advancing the techniques utilized in medical imaging and treatment. By fostering a platform for high-quality research, it aims to bridge the gap between theoretical studies and clinical applications, making it a vital addition to any medical library.

RADIATION PHYSICS AND CHEMISTRY, published by Pergamon-Elsevier Science Ltd in the United Kingdom, stands as a leading journal in the field of radiation studies, bridging fundamental research and practical applications. With an impressive 2023 Scopus Rank of 11 out of 58 in the Radiation category, reflecting an 81st percentile ranking, the journal maintains a robust reputation within the scientific community. The journal focuses on the experimental and theoretical aspects of radiation physics, chemistry, and their interdisciplinary applications, providing critical insights that aid the advancement of knowledge in various domains, including nuclear energy, materials science, and healthcare. Although open access options are not available, the journal garners substantial readership and engagement from researchers, professionals, and students alike, as it publishes innovative studies and reviews from 1985 through to its anticipated conclusion in 2025. The ISSN for the journal is 0969-806X, with the E-ISSN being 1879-0895, ensuring global accessibility to cutting-edge research in radiation science.

Radiotherapy and Oncology is a leading peer-reviewed journal published by Elsevier Ireland Ltd, focusing on the vital fields of hematology, oncology, and radiology. With an impressive impact factor and ranking in the top quartiles (Q1) of its categories as of 2023, it is recognized for disseminating high-quality research that contributes significantly to advancements in cancer treatment and patient care. The journal, which has been in circulation since 1983, aims to provide a platform for original research articles, reviews, and clinical studies that explore the latest innovations in radiotherapeutic technologies and oncology practices. This journal is essential for researchers, healthcare professionals, and students who are dedicated to improving cancer therapies and outcomes. Although it does not offer open access, the wealth of information contained within its pages supports continued education and development in these crucial medical fields.

STRAHLENTHERAPIE UND ONKOLOGIE is an esteemed journal published by Springer Heidelberg, focusing on critical advancements and research in the fields of Oncology and Radiology. Established in 1986, this journal has carved its niche within the scientific community, ranking in the Q1 category for Radiology, Nuclear Medicine and Imaging, and Q2 for Oncology as of 2023. With an ISSN of 0179-7158 and E-ISSN 1439-099X, it serves as an essential resource for researchers, professionals, and students dedicated to the complexities of cancer treatment and radiation therapy. While the journal operates under a subscription model, its broad international readership values its rigorous peer-review process and comprehensive coverage of pivotal studies. STRAHLENTHERAPIE UND ONKOLOGIE continues to enhance its impact in the domains of oncology and radiology, as evidenced by its commendable Scopus rankings, including a 76th percentile in Radiology and a 65th percentile in Oncology. Its commitment to disseminating innovative research solidifies its role as a cornerstone in the ongoing quest to improve patient care and therapeutic techniques.

HEALTH PHYSICS is a leading academic journal dedicated to the study and dissemination of knowledge in the fields of radiology, epidemiology, and health toxicology. Published by Lippincott Williams & Wilkins, this esteemed journal has been a cornerstone of research since its inception in 1958, and it continues to foster important discussions and advancements in the discipline. With a notable impact factor and consistently ranking in the Q2 and Q3 quartiles across various categories in 2023, HEALTH PHYSICS serves as a vital resource for scholars, practitioners, and students seeking the latest insights and methodologies in the management of radiation exposure and its health implications. While the journal does not offer open access, it remains a critical platform for peer-reviewed articles that contribute to public health and environmental safety. The journal's comprehensive scope and historical significance underscore its importance in advancing knowledge and practices within its field, making it an essential read for anyone engaged in the multidisciplinary realms of health physics.

International Journal of Radiation Oncology Biology Physics, published by Elsevier Science Inc, is a premier academic journal that has played a critical role in advancing the field of radiation oncology since its inception in 1975. With an impressive impact factor and recognition as a Q1 journal across multiple categories such as Cancer Research, Oncology, and Radiology, this journal serves as a vital resource for researchers, clinicians, and students dedicated to understanding and improving cancer treatment modalities. Its multifaceted scope encompasses original research, reviews, and innovative clinical studies, fostering a deeper understanding of the interplay between radiation, biology, and oncology. With a remarkable ranking in Scopus, including a top position in Radiation Physics and an elite percentile in Oncology, IJROBP remains at the forefront of scientific discovery and innovation in the management of cancer. A traditional subscription model ensures high-quality, peer-reviewed content, providing invaluable insights that continue to advance the standards of care and research in radiation oncology.

Nuclear Physics and Atomic Energy is a reputable open-access journal that focuses on the fields of nuclear physics and high-energy physics, providing a forum for researchers, professionals, and students to share their findings and advancements. Published by the Institute of Nuclear Research, National Academy of Sciences of Ukraine, this journal has been committed to disseminating knowledge since its inception in 2006, ensuring that scientific advancements remain accessible to a global audience. With an ISSN of 1818-331X and an E-ISSN of 2074-0565, the journal features a diverse array of articles that span the continued exploration and application of nuclear phenomena. Although currently categorized in the Q4 quartile for Nuclear and High Energy Physics in 2023, the journal is steadily working towards increasing its impact and engagement within the academic community. With a Scopus rank of #74 out of 87 in its category, it serves as a valuable resource for advancing crucial research in a vital scientific area. Researchers are encouraged to contribute their innovative studies to foster collaboration and knowledge sharing in this dynamic field.

RADIATION AND ENVIRONMENTAL BIOPHYSICS, published by SPRINGER, is a premier journal dedicated to advancing the understanding of the interactions between radiation and biological systems within environmental contexts. With an ISSN of 0301-634X and an E-ISSN of 1432-2099, this journal has established itself as a vital source of innovative research across multiple disciplines, including Biophysics, Environmental Science, and Radiation Studies, maintaining a significant presence since its inception in 1974. The journal is categorized within the Q3 in Biophysics and Q2 in both Environmental Science and Radiation for 2023, indicating its relevance and influence in these domains. Researchers and professionals will find the journal's rich content invaluable, offering insights that could impact public health, environmental policy, and radiation safety. Although it is not an open-access journal, RADIATION AND ENVIRONMENTAL BIOPHYSICS provides critical information through its rigorous peer-reviewed articles, making it an essential resource for academics and practitioners aiming to contribute to this evolving field.

RADIATION PROTECTION DOSIMETRY is a vital academic journal dedicated to the field of radiation protection, published by Oxford University Press. With an ISSN of 0144-8420 and an E-ISSN of 1742-3406, this journal serves as a platform for groundbreaking research and developments in dosimetry, health physics, and radiation safety spanning over four decades since its inception in 1981. Recognized with a Q3 ranking in multiple categories including Medicine (miscellaneous) and Public Health, this journal plays a key role in disseminating important findings that inform policy, enhance practice, and promote the protection of both individuals and the environment from radiation hazards. While currently not available as Open Access, the journal's curated content is essential for researchers, professionals, and students dedicated to advancing knowledge in radiation protection and related areas. Interested readers will find the latest research trends, case studies, and reviews invaluable for their work and studies within this multidisciplinary domain.

Radiation Oncology is a premier scholarly journal published by BMC, dedicated to advancing the field of oncology through innovative research and comprehensive reviews since its inception in 2005. With its Open Access model, the journal ensures that the latest findings in radiotherapy and cancer treatment are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and healthcare professionals. The journal has garnered an impressive reputation with prestigious rankings, achieving Q1 status in Radiology, Nuclear Medicine and Imaging and Q2 in Oncology as of 2023, reflecting its significant impact on the scientific community. In the Scopus rankings, it stands proud at Rank #61 in Radiology, Nuclear Medicine and Imaging, placing it in the top 81st percentile, and Rank #112 in Oncology at the 72nd percentile. With a converged publication plan extending through 2024, Radiation Oncology remains a vital resource for those dedicated to enhancing cancer treatment methodologies and outcomes.